532488 Stock Overview
Engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Divi's Laboratories Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹5,762.85 |
| 52 Week High | ₹6,276.20 |
| 52 Week Low | ₹3,350.05 |
| Beta | 0.35 |
| 11 Month Change | -4.35% |
| 3 Month Change | 22.06% |
| 1 Year Change | 56.98% |
| 33 Year Change | 23.14% |
| 5 Year Change | 226.66% |
| Change since IPO | 52,879.54% |
Recent News & Updates
Recent updates
Shareholder Returns
| 532488 | IN Life Sciences | IN Market | |
|---|---|---|---|
| 7D | -2.2% | -3.3% | -3.4% |
| 1Y | 57.0% | 46.6% | 27.0% |
Return vs Industry: 532488 exceeded the Indian Life Sciences industry which returned 46.7% over the past year.
Return vs Market: 532488 exceeded the Indian Market which returned 27.5% over the past year.
Price Volatility
| 532488 volatility | |
|---|---|
| 532488 Average Weekly Movement | 3.6% |
| Life Sciences Industry Average Movement | 6.5% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.2% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 532488 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 532488's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1990 | 9,741 | Kiran Divi | www.divislabs.com |
Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as beta carotene, astaxanthin, lycopene, and canthaxanthin, as well as other finished forms, including lutein, and vitamins to food, dietary supplement, and feed manufacturers industries. It also exports its products.
Divi's Laboratories Limited Fundamentals Summary
| 532488 fundamental statistics | |
|---|---|
| Market cap | ₹1.53t |
| Earnings (TTM) | ₹18.36b |
| Revenue (TTM) | ₹86.14b |
83.4x
P/E Ratio17.8x
P/S RatioIs 532488 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 532488 income statement (TTM) | |
|---|---|
| Revenue | ₹86.14b |
| Cost of Revenue | ₹36.76b |
| Gross Profit | ₹49.38b |
| Other Expenses | ₹31.02b |
| Earnings | ₹18.36b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 69.16 |
| Gross Margin | 57.33% |
| Net Profit Margin | 21.31% |
| Debt/Equity Ratio | 0.04% |
How did 532488 perform over the long term?
See historical performance and comparison